
Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what innovations are still expected.

Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what innovations are still expected.

Presenting what they believe are the problems and solutions, PCMA CEO David Marin and NCPA CEO Douglas Hoey, RPh, discuss the US drug pricing dilemma.

Scott Stoll and Kenzie Hohman, PharmD, discuss the importance of pharmacy advocacy, from localized efforts to federal movement across the profession.

The American Pharmacists Association, Canadian Pharmacists Association, and International Pharmaceutical Federation release plans for pharmacists’ primary care integration.

JD Power releases its US Pharmacy Digital Experience Study, highlighting the growing importance of digital solutions in pharmacy practice and business.

In part 2, Scott Stoll and Kenzie Hohman, PharmD, explain their respective advocacy efforts, highlighting the sheer range of a profession fighting for change.

Kenzie Hohman, PharmD, and Scott Stoll believe pharmacy advocacy is inherent in its workforce, despite the constant and deterrent pressures it faces.

This fall’s event will focus on the expanding role of pharmacists in providing patient care with clinical value, prevention, and more.

Researchers identify the resources and opportunities available for community pharmacies to incorporate climate-conscious health care practices.

Exploring rural and urban density data, and the factors that lead to it, researchers review community pharmacy prominence across Australia.

Through real-world strategies and examples, Duane Jones, BS Pharm, and Jennifer Griffin, PharmD, assess the pharmacist’s growing prescribing capabilities.

As pharmacy expands, experts are searching for what drives or hinders the collective growth of professional pharmacy services.

Duane Jones, BS Pharm, and Jennifer Griffin, PharmD, share real-world examples of how pharmacists’ medication expertise is transformative for patients.

With reproductive and obstetric care services waning in the US, researchers explore how patients see pharmacists filling gaps in care.

Duane Jones, BS Pharm, and Jennifer Griffin, PharmD, provide their reasons behind the need for expanding pharmacists’ prescribing abilities.

Through the scope of Nigerian pharmacists and their vaccination rates, researchers assessed strategies for advancing public health.

Rick Couldry, MS/HSPA, discusses how cloud-native software resolves fragmented systems, improves tracking, and streamlines clinical workflows.

In part 2, Rick Couldry, MS/HSPA, provides necessary nuance to the value driving cloud-based medication management to the forefront of health care.

Policy shifts in Medicare and advancements in automation are creating a massive opportunity for both revenue growth and clinical impact.

This episode provides a detailed breakdown of the CVS Caremark-FTC settlement from July, exploring a shifting landscape of pharmacy benefit management.

The current crisis of staffing shortage is not just a labor shortage but a structural failure in how pharmacies recruit and value their technician workforce.

Rick Couldry, MS/HSPA, provides his expertise for why medication management requires modernization to further streamline patient outcomes.

Although DSCSA is often viewed as a regulatory burden, pharmacy leaders illustrate its necessity through harrowing case studies of supply chain failures.

Pharmacy leaders urge regional alliances, scalable clinical services, and data exchange to make pharmacist care reimbursable and routine.

Researchers assess the effects of pharmacist support in enhancing GLP-1 access in a primary care setting.

Pharmacists must navigate peptide and GLP-1 compounding legally by understanding 503A vs 503B rules.